Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
21
|
pubmed:dateCreated |
1991-8-1
|
pubmed:abstractText |
From November 1989 to April 1990 we analyzed prospectively the prevalence of anti-hepatitis C virus antibodies and the possible mode of infection in 90 outpatients with repeatedly elevated alanine-aminotransferase levels. The clinical and serological course of these patients was evaluated after 1, 3 and 6 months. Initially, 24 patients (26.6%) were positive for anti-HCV antibodies, but subsequently only 14 of these patients (15.5%) were positive in the follow-up tests. 9 patients (10%) showed no antibodies against HCV in control evaluations and one patient dropped out of the investigation. The 9 patients with a negative result in the control tests had median relative anti-HCV concentrations of 2.0 (range 1.2-4.1) in contrast to 5.5 (range 1.6-256.5) in the 14 patients with a confirmed anti-HCV test (p less than 0.001). None of those 9 patients had received blood transfusions, 7 had consumed drugs intravenously and only 2 had no specific risk for HCV infection. The consistently anti-HCV positive patients had median alanine-aminotransferase levels between 115 and 200 U/l, whereas the levels in initially anti-HCV positive and subsequently negative patients ranged from 75-90 U/l. The initial prevalence of anti-HCV antibodies in 26.6% of our patients is related to the high rate of either false positive results or sero-conversion in 38% of this group. We recommend cautious interpretation of anti-HCV test results with relative anti-HCV concentrations less than or equal to 2 in equivocal clinical situations.
|
pubmed:language |
ger
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0036-7672
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
25
|
pubmed:volume |
121
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
804-6
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:1647550-Adult,
pubmed-meshheading:1647550-Alanine Transaminase,
pubmed-meshheading:1647550-Blood Transfusion,
pubmed-meshheading:1647550-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:1647550-Female,
pubmed-meshheading:1647550-Hepacivirus,
pubmed-meshheading:1647550-Hepatitis Antibodies,
pubmed-meshheading:1647550-Hepatitis C,
pubmed-meshheading:1647550-Humans,
pubmed-meshheading:1647550-Male,
pubmed-meshheading:1647550-Middle Aged,
pubmed-meshheading:1647550-Prospective Studies,
pubmed-meshheading:1647550-Risk Factors
|
pubmed:year |
1991
|
pubmed:articleTitle |
[Prevalence and significance of ant-HCV-antibodies in ambulatory patients with raised transaminases].
|
pubmed:affiliation |
Abteilung für Gastroenterologie, Universitätsspital Zürich.
|
pubmed:publicationType |
Journal Article,
English Abstract
|